ANGI Insider Activity: Sandra Buchanan Receives 16,436 Stock Units

Rhea-AI Filing Summary

Form 4 snapshot: On 06/17/2025 Angi Inc. (ANGI) director Sandra M. Buchanan reported an award of 16,436 restricted stock units (RSUs). The transaction code “A” confirms it was a grant, not a market purchase or sale, and was executed at $0 cost under the company’s equity compensation plan. Each RSU converts into one share of Class A common stock.

The RSUs vest in three equal annual installments on each anniversary of the 06/17/2025 grant date, contingent on continued board service. Under Buchanan’s deferral election, any vested shares will be delivered in a lump-sum after her service ends. After this grant, she beneficially owns 16,436 derivative securities, held directly. No dispositions or additional transactions were disclosed.

No ordinary shares were bought or sold, and the filing does not reference a Rule 10b5-1 trading plan. The event is a routine director compensation grant with minimal direct market impact.

Positive

• Director received 16,436 RSUs, increasing insider-aligned ownership without immediate dilution.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine 16,436-unit RSU grant to Angi director; no cash outlay, no share sale, negligible valuation impact.

The filing records an automatic equity award rather than an active insider purchase. While it increases insider-aligned ownership, it doesn’t signal new confidence through capital deployment. Vesting over three years promotes director retention, but settlement is deferred until service ends, delaying dilution. With Angi’s ~250 m outstanding shares, 16.4 k units represent <0.01%, so dilution risk and valuation impact are immaterial. Overall, the disclosure is governance-related rather than a trading signal; investors should view it as neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buchanan Sandra M

(Last) (First) (Middle)

C/O ANGI INC.

3601 WALNUT STREET, SUITE 700

(Street)

DENVER CO 80205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Angi Inc. [ ANGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/17/2025		A		16,436		(2)	(2)	Class A Common Stock, par value $0.001	16,436	$0	16,436	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.

2. Represents RSUs that vest in equal installments over three years on the anniversary of the grant date (June 17, 2025), subject to continued service. Pursuant to the reporting person's deferral election, any vested RSUs will be settled in a lump sum following termination of service.

Remarks:

	Shannon M. Shaw as Attorney-in-Fact for Sandra Buchanan	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Angi Inc. (ANGI) report on 06/17/2025?

A grant of 16,436 restricted stock units to director Sandra M. Buchanan.

How many shares are covered by Sandra Buchanan's RSU grant?

The grant covers 16,436 shares of Angi Class A common stock.

When will the RSUs granted to the Angi director vest?

They vest in three equal annual installments on each anniversary of 06/17/2025, subject to continued service.

Did the filing disclose any sales of Angi stock by the director?

No; the Form 4 shows only an award, with no dispositions reported.

Is the RSU grant part of a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was executed under a 10b5-1 plan.